First Header Logo Second Header Logo

Connection

Michael Cartwright to Oligonucleotides, Antisense

This is a "connection" page, showing publications Michael Cartwright has written about Oligonucleotides, Antisense.
  1. Cartwright MS, Upadhya S. Selecting disease-modifying medications in 5q spinal muscular atrophy. Muscle Nerve. 2021 Oct; 64(4):404-412.
    View in: PubMed
    Score: 0.798
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.